Skip to content
10-Q

Quarterly Report

Universal Biosensors, Inc.

0001437749-24-014273

← back to feed
Filed
May 2, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 2, 2024 231.4M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 7.04M
Cash And Equivalents Q1 2024 · Dec 31, 2023 10.24M
Current Liabilities Q1 2024 · Mar 31, 2024 4.85M
Current Liabilities Q1 2024 · Dec 31, 2023 5.95M
Total Liabilities Q1 2024 · Mar 31, 2024 9.23M
Total Liabilities Q1 2024 · Dec 31, 2023 10.47M
Current Assets Q1 2024 · Mar 31, 2024 20.06M
Current Assets Q1 2024 · Dec 31, 2023 22M
Total Assets Q1 2024 · Mar 31, 2024 27.9M
Total Assets Q1 2024 · Dec 31, 2023 29.97M
Capex Q1 2024 · Mar 31, 2023 404.38K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −5.81M
Stockholders Equity Q1 2024 · Mar 31, 2023 22.27M
Stockholders Equity Q1 2024 · Dec 31, 2022 26.09M
Eps Basic Q1 2024 · Mar 31, 2023 −0.02
Sga Expense restated Q1 2024 · Mar 31, 2023 3.32M
Rd Expense Q1 2024 · Mar 31, 2023 1.85M
Net Income Q1 2024 · Mar 31, 2023 −3.79M
Operating Income Q1 2024 · Mar 31, 2023 −4.52M
Gross Profit Q1 2024 · Mar 31, 2023 876.78K
Cost Of Revenue Q1 2024 · Mar 31, 2023 418.69K